Ganglioside composition and its relation to clinical data in brain tumors
Shinoura N., Dohi T., Kondo T., Yoshioka M., Takakura K., Oshima M. Ganglioside composition and its relation to clinical data in brain tumors. Neurosurgery. 31:1992;541-549.
Gangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors
Sung C.-C., Pearl D.K., Coons S.W., Scheithauer B.W., Johnson P.C., Yartes A.J. Gangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors. Cancer. 74:1994;3010-3022.
Expression of gangliosides GD3 and 3′-isoLM1 in autopsy brain from patients with malignant tumors
Fredman P., Holst H.V., Collins V.P., Dellheden B., Svennerholm L. Expression of gangliosides GD3 and 3′-isoLM1 in autopsy brain from patients with malignant tumors. J Neurochem. 60:1993;99-105.
Embryonic stem cells with a disrupted GD3 synthase gene undergo neuronal differentiation in the absence of b-series gangliosides
Kawai H., Sango K., Mullin K.A., Proia R.L. Embryonic stem cells with a disrupted GD3 synthase gene undergo neuronal differentiation in the absence of b-series gangliosides. J Biol Chem. 273:1998;4-19638.
Cell-surface antigens of melanoma recognized by human monoclonal antibodies
Livingston P.O., Natoli E.J., Calves M.J., Stockert E., Oettgen H.F., Old L.J. Cell-surface antigens of melanoma recognized by human monoclonal antibodies. Proc Natl Acad Sci USA. 84:1987;2911-2915.